Investors
Issue Archive
Document | File | Date |
---|---|---|
Rights Issue 2023 | ||
EU-tillväxtprospekt | ||
Emissionsfolder | ||
Anmälningssedel för teckning av aktier med stöd av teckningsrätter | ||
Anmälningssedel för teckning av aktier utan stöd av teckningsrätter | ||
The board of directors’ resolution on rights issue | ||
The board of directors’ report | ||
Auditor’s statement | ||
Directed Issue 2023 | ||
The board of directors’ resolution on directed set-off issue | ||
The board of directors’ report | ||
Auditor’s statement | ||
TO1 2022 | ||
Informationsblad TO1 | May 19 2022 | |
Anmälningssedel | May 19 2022 | |
Terms for warrants of series TO1 | June 22 2021 | |
IPO 2021 | ||
Tilläggsdokument avseende notering av Modus Therapeutics Holding AB (Swedish Only) | July 20 2021 | |
The offer in summary | June 22 2021 | |
Subscribe units in Modus | June 30 2021 | |
Prospectus-Modus | June 29 2021 | |
Prospectus-Summary-Finnish | June 29 2021 | |
Prospectus-Summary-Norwegian | June 29 2021 | |
Teaser-English | June 29 2021 | |
Teaser-Danish | June 29 2021 | |
Terms for warrants of series TO1 | June 22 2021 | |
Basic information document | June 29 2021 |